COVID-19 and the endocrine system: a comprehensive review on the theme
G Lisco, A De Tullio, A Stragapede… - Journal of clinical …, 2021 - mdpi.com
Background and aim. The review aimed to summarize advances in the topic of endocrine
diseases and coronavirus disease 2019 (COVID-19). Methods. Scientific and institutional …
diseases and coronavirus disease 2019 (COVID-19). Methods. Scientific and institutional …
COVID19 biomarkers: What did we learn from systematic reviews?
S Semiz - Frontiers in cellular and infection microbiology, 2022 - frontiersin.org
The coronavirus disease 2019 (COVID19) pandemic continues to represent a substantial
public health concern. It can rapidly progress to severe disease, with poor prognosis and a …
public health concern. It can rapidly progress to severe disease, with poor prognosis and a …
[HTML][HTML] Cardiometabolic outcomes up to 12 months after COVID-19 infection. A matched cohort study in the UK
Background Acute Coronavirus Disease 2019 (COVID-19) has been associated with new-
onset cardiovascular disease (CVD) and diabetes mellitus (DM), but it is not known whether …
onset cardiovascular disease (CVD) and diabetes mellitus (DM), but it is not known whether …
Criteria for iron deficiency in patients with heart failure
Background Guidelines on heart failure (HF) define iron deficiency (ID) as a serum ferritin<
100 ng/mL or, when 100-299 ng/mL, a transferrin saturation (TSAT)< 20%. Inflammation …
100 ng/mL or, when 100-299 ng/mL, a transferrin saturation (TSAT)< 20%. Inflammation …
Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome
Aims We investigated the incidence, risk factors, clinical characteristics, and outcomes of
pulmonary embolism (PE) in patients with COVID-19 attending emergency departments …
pulmonary embolism (PE) in patients with COVID-19 attending emergency departments …
Prevalence of atrial fibrillation and associated mortality among hospitalized patients with COVID-19: a systematic review and meta-analysis
Background: Epidemiological studies have shown that atrial fibrillation (AF) is a potential
cardiovascular complication of coronavirus disease 2019 (COVID-19). We aimed to perform …
cardiovascular complication of coronavirus disease 2019 (COVID-19). We aimed to perform …
Prevalence and risk of new-onset diabetes mellitus after COVID-19: a systematic review and meta-analysis
Aims After the acute phase of SARS-CoV-2 infection, the onset of glycemic impairment and
diabetes have been reported. Nevertheless, the exact burden of glycemic impairment and …
diabetes have been reported. Nevertheless, the exact burden of glycemic impairment and …
Incidence of cardiac complications following COVID-19 infection: An umbrella meta-analysis study
Background COVID-19 causes fatal cardiac damages. Despite many overwhelming meta-
analysis related to cardiac complications following COVID-19 disease, no umbrella meta …
analysis related to cardiac complications following COVID-19 disease, no umbrella meta …
Acute cardiac events during COVID-19-associated hospitalizations
Background COVID-19 is associated with cardiac complications. Objectives The purpose of
this study was to estimate the prevalence, risk factors, and outcomes associated with acute …
this study was to estimate the prevalence, risk factors, and outcomes associated with acute …
COVID-19-associated pulmonary embolism: review of the pathophysiology, epidemiology, prevention, diagnosis, and treatment
COVID-19 is associated with endothelial activation in the setting of a potent inflammatory
reaction and a hypercoagulable state. The end result of this thromboinflammatory state is an …
reaction and a hypercoagulable state. The end result of this thromboinflammatory state is an …